SR One co-led antibody therapy developer Ancora Biotech's $60m series A round while Al-Dhow Engineering helped coffee chain Flash Coffee secure $32.8m.
Funding
Ancora Biotech, a Switzerland-based developer of antibody-driven therapeutics, has raised $60m in a series A round co-led by SR One, the venture capital firm spun off by pharmaceutical firm GlaxoSmithKline, and private equity firm Lightspeed Venture Partners.
Stake sale
Consumer intelligence software provider Affle Global has paid approximately $11.8m for an additional 13.1% stake in India-based content curation app Indus OS (OSlabs) from Samsung Ventures, a subsdiary of cosnumer electronics manufacturer Samsung, through a secondary transaction the Business Standard…
